Yvonne Huang, MD and Robert Dickson, MD found unusual microbial communities in a person’s lower airways could influence the onset and progression of lung cancer and other conditions and might point the way to therapies.
Yvonne Huang, MD and Robert Dickson, MD found unusual microbial communities in a person’s lower airways could influence the onset and progression of lung cancer and other conditions and might point the way to therapies.
Jason Knight, MD, PhD, and team’s discovery raises hope for more targeted approaches to treatment of an autoimmune blood clotting disorder.
Sean Fortier, MD and Mark Peters-Golden, MD uncover a pathway used during normal wound healing that has the potential to reverse IPF.
H. David Humes, MD states, “Our technology focuses not on treating the bacteria, but treating this dysregulated immunologic system that is overreacting and destroying tissues within the body. That's the breakthrough with this technology.”
Mueesh Tewari, MD, PhD, Paul Swiecicki, MD, and team have created an at home test that can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests.
Jacob Kurlander, MD MS, and team find the potential promise, and pitfalls, of a massive effort to reduce overuse of a common class of heartburn medications known as proton pump inhibitors or PPIs.
Hitinder Grum, MBBS is quoted saying, “The vast majority of deaths after PCI are unpreventable and related to patients’ underlying conditions for which they are undergoing the procedure. This is a stark change from the 1990s when most deaths were traceable to procedural complications.”
Ponni Perumalswami, MD, and team found that telehealth for alcohol use disorder treatment supported a greater number of psychotherapy visits and longer duration of medication treatment in VHA patients.
Geoffrey Barnes, MD, and team find the use of a population health dashboard provides an efficient method of identifying patients on DOACs that require dose adjustments or therapeutic modifications.
Jeremy Sussman, MD and team shed new light on the key role that primary care providers play in cardiovascular risk factor management.
Pratima Sharma, MD, and team examine the challenges and opportunities in the care of liver transplant candidates and recipients with alcohol use disorder.
Kim Eagle, MD gives insight on a new study that suggests Beta blockers do not significantly reduce combined risk of death or new heart attack for patients who have preserved ejection fraction after a heart attack.
Ponni Perumalswami, MD and team found higher HCV cure rates with facilitated telemedicine integrated into opioid treatment programs.
Eric Brandt, MD discusses ways to manage cholesterol including a combination of lifestyle and, when needed, medications.
Kathleen Collins, MD, and teams’ findings offer a new path forward in the development of drugs that could potentially help cure – rather than treat – HIV.
A team of researchers from Michigan Medicine's MEND division link the homeostatic balance of ER-to-Golgi trafficking to a more favorable proinsulin folding outcome.
Ashwin Gupta, MD, and team find the inappropriate diagnosis of pneumonia among hospitalized adults is common and may be harmful.
Geoffrey Barnes, MD, spoke with the Detroit Free Press to explore how blood clots can affect athletes under high cardiovascular strain.
Thomas Crawford, MD, and team hope to increase pacemaker access and implantation in low- and middle-income countries through an innovative trial.
